Pharmaceutical giant Pfizer recently announced stunning progress on a COVID-19 vaccine which worked with 90 percent efficiency. The news was welcomed all around the globe, as the end of the pandemic could be nearing.
Now, one company believes employees could be rolled back into the office in January in the US as the end is seemingly now in sight.
Work Care, a company which offers safety practices for offices, believes the vaccine is positive news for companies in the States.
Dr, Anthony Harris, M.D., M.B.A., M.P.H., the Chief Innovation Officer and Associate Medical Director for WorkCare, told Express.co.uk: “Returning to work in January is definitely a possibility with combined vaccinations and still implementing those social distance measures and mask mandates just for an extra measure.
“Both of these things together will go a long way in fighting COVID.”
Other scientists, however, warn there is still a long way to go before we are back to normality.
Daniel M. Davis, Professor of Immunology at The University of Manchester and author of The Beautiful Cure, a book about the immune system said: “This is a watershed moment. For the first time, there is evidence that one of the possible vaccines for COVID-19 can protect people from the disease.
“It is early days still and it is important to remember that there are caveats: we need to be able scrutinise the data independently, and we don’t yet know how long immunity may last for.
“The safety data isn’t yet sufficiently robust so that this medicine could be approved formally yet.
READ MORE: Paul McCartney says some pals ‘were close to going under’ with COVID
He said: “The good news is that vaccines really are being developed quickly, there are already some retroviral drugs and health professionals know much more of how to treat it, so fewer people are dying.
“There has never been such a concerted effort put into vaccine research.
“The first vaccines could come by the end of December and by the middle of next year should be readily available.
“However, even if we get a vaccine by May or June, it will still take another year to knock it right back. My view is we won’t fully be out of this until the spring of 2022.”